msr2903/mrm8488-distilroberta-fine-tuned-financial-sentiment
Text Classification
•
Updated
•
17
symbol
stringlengths 2
11
| publishedDate
stringlengths 24
24
| title
stringlengths 7
369
| image
stringlengths 0
283
| site
stringclasses 13
values | text
stringlengths 0
503
| url
stringlengths 36
1.1k
| sentiment
stringclasses 3
values | sentimentScore
float64 -1
1
⌀ |
---|---|---|---|---|---|---|---|---|
HE | 2023-10-04T21:54:28.000Z | HE REMINDER: Kessler Topaz Meltzer & Check, LLP Reminds Hawaiian Electric Industries, Inc. (HE) Shareholders of Securities Fraud Class Action Lawsuit and Encourages Investors with Substantial Losses to Contact the Firm | /next-assets/images/schema-image-default.png | benzinga | RADNOR, Pa., Oct. 04, 2023 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Northern District of California against Hawaiian Electric Industries, Inc. ("Hawaiian Electric") (NYSE:HE). The action charges Hawaiian Electric with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the compa... | https://www.benzinga.com/pressreleases/23/10/g35098825/he-reminder-kessler-topaz-meltzer-check-llp-reminds-hawaiian-electric-industries-inc-he-shareholde | Negative | -0.6417 |
CRS | 2023-10-04T21:40:00.000Z | Carpenter Technology Announces Conference Call and Webcast | https://ml.globenewswire.com/Resource/Download/7c55611a-3a49-4ccf-ba73-ce17859753db | globenewswire | PHILADELPHIA, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Carpenter Technology Corporation (NYSE: CRS) plans to host a conference call and webcast on Thursday, October 26, 2023 at 10:00 a.m. ET to discuss the results of operations for the first quarter of fiscal year 2024, ended September 30, 2023. The call and webcast will follow the release of first quarter fiscal 2024 financial results before the market opens on Thursday, October 26, 2023... | https://www.globenewswire.com/news-release/2023/10/04/2754991/0/en/Carpenter-Technology-Announces-Conference-Call-and-Webcast.html | Positive | 0.4767 |
BB | 2023-10-04T21:34:09.000Z | What's Going On With BlackBerry Stock After Hours? | benzinga | BlackBerry Ltd (NYSE: BB) shares are trading higher in Wednesday's after-hours session after the company announced intent to separate its business units. What Happened: As a result of the company's previously announced strategic review to drive shareholder value, BlackBerry's board determined that separating its IoT and Cybersecurity businesses is the best strategy for the company. BlackBerry plans to pursue an IPO for its IoT business sometime in the ...Full story available on Benzinga.com... | https://www.benzinga.com/news/23/10/35098537/whats-going-on-with-blackberry-stock-after-hours | Positive | 0.9895 |
|
TECK | 2023-10-04T21:17:00.000Z | Teck to Release Third Quarter 2023 Results on October 24, 2023 | https://ml.globenewswire.com/Resource/Download/4d859d20-8bc9-4aa6-9ff8-006dbd1d33f2 | globenewswire | VANCOUVER, British Columbia, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Teck Resources Limited (TSX: TECK.A and TECK.B, NYSE: TECK) (“Teck”) will release its third quarter 2023 earnings results before market open on Tuesday, October 24, 2023... | https://www.globenewswire.com/news-release/2023/10/04/2754989/0/en/Teck-to-Release-Third-Quarter-2023-Results-on-October-24-2023.html | Positive | 0.83 |
AGF | 2023-10-04T21:13:38.000Z | AGF Reports September 2023 Assets Under Management and Fee-Earning Assets | /next-assets/images/schema-image-default.png | benzinga | TORONTO, Oct. 04, 2023 (GLOBE NEWSWIRE) -- AGF Management Limited reported total assets under management (AUM) and fee-earning assets1 of $41.0 billion as at September 30, 2023. AUM ($ billions) September 30, 2023 August 31, 2023 % ChangeMonth-Over-Month September 30, 2022 % Change Year-Over-Year Total Mutual Fund (including retail pooled funds) $23.5 $24.4 $21.7 Exchange-traded funds + Separately managed accounts $1.4 $1.3 $1.1 Segregated accounts and Sub-advisory + AGF Priva... | https://www.benzinga.com/pressreleases/23/10/g35098361/agf-reports-september-2023-assets-under-management-and-fee-earning-assets | Positive | 0.9768 |
AGF | 2023-10-04T21:13:00.000Z | AGF Reports September 2023 Assets Under Management and Fee-Earning Assets | https://ml.globenewswire.com/Resource/Download/624b638e-e8de-4533-84a1-624de8827cf1 | globenewswire | TORONTO, Oct. 04, 2023 (GLOBE NEWSWIRE) -- AGF Management Limited reported total assets under management (AUM) and fee-earning assets1 of $41.0 billion as at September 30, 2023... | https://www.globenewswire.com/news-release/2023/10/04/2754986/0/en/AGF-Reports-September-2023-Assets-Under-Management-and-Fee-Earning-Assets.html | Positive | 0.9834 |
AGF | 2023-10-04T21:02:00.000Z | AGF déclare le total de son actif géré et de ses actifs donnant droit à des commissions pour septembre 2023 | https://ml.globenewswire.com/Resource/Download/50199847-86f9-48ba-bcb2-084863a9fa06 | globenewswire | TORONTO, 04 oct. 2023 (GLOBE NEWSWIRE) -- La Société de Gestion AGF Limitée a déclaré un actif géré global, ainsi que des actifs donnant droit à des commissions1, totalisant 41,0 milliards $, au 30 septembre 2023... | https://www.globenewswire.com/news-release/2023/10/04/2754984/0/fr/AGF-d%C3%A9clare-le-total-de-son-actif-g%C3%A9r%C3%A9-et-de-ses-actifs-donnant-droit-%C3%A0-des-commissions-pour-septembre-2023.html | Neutral | 0 |
LGIH | 2023-10-04T21:00:00.000Z | LGI Homes Reports September and Third Quarter Home Closings and Announces Date for Third Quarter Earnings Conference Call | globenewswire | LGI Homes reports September and third quarter home closings and announces date for third quarter earnings conference call... | https://www.globenewswire.com/news-release/2023/10/04/2754982/28788/en/LGI-Homes-Reports-September-and-Third-Quarter-Home-Closings-and-Announces-Date-for-Third-Quarter-Earnings-Conference-Call.html | Positive | 0.9899 |
|
GDL | 2023-10-04T21:00:00.000Z | Goodfellow annonce ses résultats pour son troisième trimestre terminé le 31 août 2023 et déclare un dividende | https://ml.globenewswire.com/Resource/Download/346e6760-b69f-4b2f-80bf-b43dcb34e0e6 | globenewswire | DELSON, Québec, 04 oct. 2023 (GLOBE NEWSWIRE) -- Goodfellow inc. (TSX : GDL) (la « Société ») annonce aujourd’hui ses résultats financiers pour le troisième trimestre terminé le 31 août 2023... | https://www.globenewswire.com/news-release/2023/10/04/2754981/0/fr/Goodfellow-annonce-ses-r%C3%A9sultats-pour-son-troisi%C3%A8me-trimestre-termin%C3%A9-le-31-ao%C3%BBt-2023-et-d%C3%A9clare-un-dividende.html | Negative | -0.0516 |
GDL | 2023-10-04T21:00:00.000Z | Goodfellow Reports Its Results for the Third Quarter Ended August 31, 2023 and Declares Dividend | https://ml.globenewswire.com/Resource/Download/ad740a03-256c-4714-a3bd-e3de035aede9 | globenewswire | GOODFELLOW INC. RESULTS FOR Q3 ENDED AUGUST 31, 2023 AND DECLARES DIVIDEND. RÉSULTATS POUR GOODFELLOW POUR SON T3 ET DÉCLARE UN DIVIDENDE... | https://www.globenewswire.com/news-release/2023/10/04/2754981/0/en/Goodfellow-Reports-Its-Results-for-the-Third-Quarter-Ended-August-31-2023-and-Declares-Dividend.html | Positive | 0.9911 |
OCEA | 2023-10-04T20:56:00.000Z | Updated: Ocean Biomedical Announces Non-Dilutive Amendment to Existing Agreement with Polar Multi-Strategy Master Fund | https://ml.globenewswire.com/Resource/Download/23cba9ce-1bc6-4226-9c6b-e5561047b289 | globenewswire | Providence, RI, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (NASDAQ: OCEA) announces that the company and Polar Multi-Strategy Master Fund (Polar) entered into a Side Letter related to the Forward Purchase Agreement entered into in February 2023... | https://www.globenewswire.com/news-release/2023/10/04/2754978/0/en/Updated-Ocean-Biomedical-Announces-Non-Dilutive-Amendment-to-Existing-Agreement-with-Polar-Multi-Strategy-Master-Fund.html | Positive | 0.9922 |
WOR | 2023-10-04T20:55:00.000Z | Worthington Industries Announces Public Filing of Form 10 Registration Statement | https://ml.globenewswire.com/Resource/Download/cebb61b5-d2f9-482f-9c43-7ee9e0938c9a | globenewswire | Public filing of a Form 10 registration statement with the U.S. SEC in connection with the planned separation of Worthington Steel... | https://www.globenewswire.com/news-release/2023/10/04/2754977/0/en/Worthington-Industries-Announces-Public-Filing-of-Form-10-Registration-Statement.html | Positive | 0.9996 |
VCYT | 2023-10-04T20:52:41.000Z | Veracyte Stock Is Volatile After-Hours - Here's Why | benzinga | Veracyte, Inc. (NASDAQ: VCYT) shares are volatile after-hours on Wednesday after the company announced that new data from a phase 3 trial validates the value of the Decipher Prostate Genomic Classifier in assisting physicians make more informed treatment decisions for their patients with prostate cancer. What To Know: The data was revealed at the 2023 American Society for Radiation Oncology (ASTRO) ...Full story available on Benzinga.com... | https://www.benzinga.com/news/23/10/35097954/veracyte-stock-is-volatile-after-hours-heres-why | Positive | 0.875 |
|
XOM | 2023-10-04T20:50:09.000Z | ExxonMobil Faces Political Headwinds: UK's Controversial Oil Field Approval and Iraq's Emphasis on Integrated Oil Development | benzinga | Exxon Mobil Corporation (NYSE: XOM) is navigating a complex political landscape, with recent developments in the U.K. and Iraq highlighting the challenges and opportunities the company faces in the global oil and gas sector. Rosebank Oil Field Approval in the UK: The UK's decision to approve the Rosebank oil field has raised eyebrows among environmentalists and climate activists. The approval granted by the North Sea Transition Authority (NSTA) seems to be at odds with global efforts to combat... | https://www.benzinga.com/news/23/10/35097962/exxonmobil-faces-political-headwinds-uks-controversial-oil-field-approval-and-iraqs-emphasis-on-inte | Positive | 0.9881 |
|
RIOT | 2023-10-04T20:45:00.000Z | Riot Announces September 2023 Production and Operations Updates | https://ml.globenewswire.com/Resource/Download/d4be0f07-52bb-40ee-8322-585e12988f2a | globenewswire | Riot Produces 362 Bitcoin in September 2023 While Continuing to Execute Power Strategy Riot Produces 362 Bitcoin in September 2023 While Continuing to Execute Power Strategy... | https://www.globenewswire.com/news-release/2023/10/04/2754973/0/en/Riot-Announces-September-2023-Production-and-Operations-Updates.html | Positive | 0.9864 |
CHDN | 2023-10-04T20:39:00.000Z | Churchill Downs Incorporated 2023 Third Quarter Financial Results Conference Call Invitation | https://ml.globenewswire.com/Resource/Download/667a7329-b6d8-4919-90bb-bc97849a9f64 | globenewswire | LOUISVILLE, Ky., Oct. 04, 2023 (GLOBE NEWSWIRE) -- Churchill Downs Incorporated (“CDI” or “the Company”) announced today that the Company will release third quarter 2023 financial results after the market closes on Wednesday, October 25, 2023, and host a related conference call to discuss the quarter on Thursday, October 26, 2023, at 9 a.m. ET... | https://www.globenewswire.com/news-release/2023/10/04/2754972/12388/en/Churchill-Downs-Incorporated-2023-Third-Quarter-Financial-Results-Conference-Call-Invitation.html | Positive | 0.959 |
ACCD | 2023-10-04T20:37:13.000Z | Why Accolade Stock Is Falling After-Hours | benzinga | Accolade, Inc. (NASDAQ: ACCD) shares are trading lower after-hours on Wednesday after the company announced results for the second-quarter 2024 and issued guidance. What To Know: The company posted second-quarter earnings of losses of 43 cents per share and sales of $96.90 million, beating the $94.09 million estimate. Accolade anticipates third-quarter revenue to be in a range between $95 million and $97 million, versus the $96.57 million estimate. The company sees full-year 2024 revenue between... | https://www.benzinga.com/news/23/10/35097485/why-accolade-stock-is-falling-after-hours | Positive | 0.9779 |
|
PRH | 2023-10-04T20:35:00.000Z | Pearl River Announces Filing of Amended and Restated Interim Financial Statements | https://ml.globenewswire.com/Resource/Download/1412bb4b-4de2-48c9-b44e-a0f05d08f457 | globenewswire | LONDON, Ontario, Oct. 04, 2023 (GLOBE NEWSWIRE) -- PEARL RIVER HOLDINGS LIMITED (“Pearl River”) (TSXV: PRH) announced today that it has filed amended and restated financial statements for the interim period ended June 30, 2023 (the “Amended Financial Statements”) to correct an error discussed below... | https://www.globenewswire.com/news-release/2023/10/04/2754971/0/en/Pearl-River-Announces-Filing-of-Amended-and-Restated-Interim-Financial-Statements.html | Positive | 0.6775 |
CNHI | 2023-10-04T20:30:00.000Z | CNH Industrial: Periodic Report on $300 Million Buyback Program | https://ml-eu.globenewswire.com/Resource/Download/f6a4f650-cfc5-4dd4-a7b3-4568c2092890 | globenewswire | Basildon, October 4, 2023... | https://www.globenewswire.com/news-release/2023/10/04/2754970/0/en/CNH-Industrial-Periodic-Report-on-300-Million-Buyback-Program.html | Positive | 0.9914 |
AGRX | 2023-10-04T20:30:00.000Z | Agile Therapeutics Reports an Inducement Grant to New Chief Financial Officer Under Nasdaq Listing Rule 5635(c)(4) | https://ml.globenewswire.com/Resource/Download/99279611-bca9-42ad-84ee-0ffa6e90c2fb | globenewswire | PRINCETON, N.J., Oct. 04, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced the granting of a previously disclosed inducement award to the Company’s newly appointed Chief Financial Officer, Scott Coiante. In accordance with Nasdaq Listing Rule 5635(c)(4), the award was approved by the Company's Compensation Committee and made as a material inducement to Mr. Coiante’s entry into employment with the Company... | https://www.globenewswire.com/news-release/2023/10/04/2754967/30925/en/Agile-Therapeutics-Reports-an-Inducement-Grant-to-New-Chief-Financial-Officer-Under-Nasdaq-Listing-Rule-5635-c-4.html | Positive | 0.9721 |
IDT | 2023-10-04T20:30:00.000Z | IDT Corporation to Report Fourth Quarter and Fiscal 2023 Results | https://ml.globenewswire.com/Resource/Download/1bc888bb-a67f-45da-a62f-40c0a4711bd5 | globenewswire | NEWARK, NJ, Oct. 04, 2023 (GLOBE NEWSWIRE) -- IDT Corporation (NYSE: IDT), a global provider of fintech, cloud communications, and traditional communications services, has scheduled its report of financial and operational results for the fourth quarter and fiscal year 2023 (the three months and twelve months ended July 31, 2023) on Thursday, October 12, 2023... | https://www.globenewswire.com/news-release/2023/10/04/2754966/0/en/IDT-Corporation-to-Report-Fourth-Quarter-and-Fiscal-2023-Results.html | Positive | 0.9747 |
ISPO | 2023-10-04T20:30:00.000Z | Inspirato Completes $25 Million Investment from Capital One Ventures, Solidifying New Strategic Partnership | https://ml.globenewswire.com/Resource/Download/d3c8339d-8bf5-4b16-8d0c-143538fac03f | globenewswire | DENVER, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Inspirato Incorporated (“Inspirato”) (NASDAQ: ISPO), the innovative luxury travel subscription brand, today announced that it has closed its $25 million senior secured convertible note issued by Inspirato to Capital One Ventures (the “investment”). On September 26, 2023, Inspirato shareholders voted to approve the investment, subject to the finalization of a commercial agreement between an affiliate of Capital One Ventures and Inspirato, which has been... | https://www.globenewswire.com/news-release/2023/10/04/2754969/0/en/Inspirato-Completes-25-Million-Investment-from-Capital-One-Ventures-Solidifying-New-Strategic-Partnership.html | Positive | 0.977 |
FVRR | 2023-10-04T20:24:40.000Z | Fiverr's Promise In 2024: Analyst Sees Upswing Despite Current Market Uncertainty | benzinga | UBS analyst Kunal Madhukar initiated coverage on the shares of Fiverr International Ltd (NYSE: FVRR) with a Buy rating and a price target of $33. The analyst believes FVRR's volumes lead overall job listings by two or more quarters, and job listings have started stabilizing. Expectations are low, and while macro remains uncertain, the analyst sees scope for expectations and multiples to trend up as the outlook firms up in 2024. The analyst sees significant upside from ...Full story available on... | https://www.benzinga.com/analyst-ratings/analyst-color/23/10/35094606/fiverrs-promise-in-2024-analyst-sees-upswing-despite-current-market-uncertainty | Positive | 0.7387 |
|
AMD | 2023-10-04T20:24:36.000Z | Is AMD Losing Samsung? Tech Behemoth Considers Independent GPU Development | benzinga | Samsung Electronics Co Ltd (OTC: SSNLF) is reportedly on the brink of a significant shift in its approach to smartphone GPU technology. The tech giant, renowned for its innovative and competitive edge in the global market, is rumored to be considering the development of its own custom GPU, potentially marking the end of its partnership with Advanced Micro Devices, Inc (NASDAQ: AMD). Also Read: AMD's AI and Data Center Prospects Eyeing Market Share Growth, Analysts Say The speculation stems from... | https://www.benzinga.com/news/23/10/35090695/is-amd-losing-samsung-tech-behemoth-considers-independent-gpu-development | Positive | 0.9697 |
|
HPLT | 2023-10-04T20:24:00.000Z | Home Plate Acquisition Corporation Announces Cancellation of Special Meeting of Stockholders and Liquidation | https://ml.globenewswire.com/Resource/Download/9a4fd0bb-8984-4f7f-98b6-6bebbc1000a9 | globenewswire | NEW YORK, Oct. 04, 2023 (GLOBE NEWSWIRE) -- This press releases amends and restates Home Plate Acquisition Corporation’s (the “Company” or “Home Plate”) (NASDAQ: HPLT) press release dated October 3, 2023. Yesterday, the Company announced that the Company has cancelled its special meeting of stockholders that was previously scheduled for 3:00 p.m. Eastern Time on October 3, 2023, and that, because the Company will not consummate an initial business combination by October 4, 2023, the time perio... | https://www.globenewswire.com/news-release/2023/10/04/2754964/0/en/Home-Plate-Acquisition-Corporation-Announces-Cancellation-of-Special-Meeting-of-Stockholders-and-Liquidation.html | Positive | 0.9904 |
FLR | 2023-10-04T20:22:59.000Z | Fluor's Financial Turnaround: Analyst Anticipates Cash Boosts And Revenue CAGR Of 9% Through 2025 | benzinga | UBS analyst Steven Fisher upgraded Fluor Corporation (NYSE: FLR) to Buy from Neutral, raising the price target to $47 from $35. The analyst writes that the company is at an inflection point, with legacy risk concerns being addressed and a return to normalized margins anticipated. Fisher expects a 41% growth in adjusted EBITDA from 2023 to 2025, driven by a 160 bps expansion in segment margin. According to the analyst, cash flow adds further upside, with favorable resolutions in negotiations, n... | https://www.benzinga.com/analyst-ratings/analyst-color/23/10/35095183/fluors-financial-turnaround-analyst-anticipates-cash-boosts-and-revenue-cagr-of-9-t | Positive | 0.9853 |
|
INTC | 2023-10-04T20:20:37.000Z | Analysts Maintain Intel's Rating Unmoved Amid Programmable Solutions Group Spinoff | benzinga | Rosenblatt analyst Hans Mosesmann reiterated Intel Corp (NASDAQ: INTC) with a Sell and a $17 price target. Intel shared plans to spin off its Programmable Solutions Group business as a standalone business, giving it flexibility for accelerated growth and helping it to compete more effectively. The move is more tactical than strategic, as Intel is cash-starved, the analyst writes. Intel mismanaged Altera early on and has only recently begun a reinvestment and focus initiative likely related to th... | https://www.benzinga.com/news/23/10/35092769/analysts-maintain-intels-rating-unmoved-amid-programmable-solutions-group-spinoff | Positive | 0.9804 |
|
FOMC | 2023-10-04T20:16:00.000Z | : This is the No. 1 most-recommended savings account in October 2023 — and it’s paying an enticing 5.25% | https://images.mktw.net/im-833731?width=700&height=467 | marketwatch | We analyzed savings account reviews from 10 of the leading financial sites in America to find out which were the most often recommended... | http://www.marketwatch.com/news/story.asp?guid=%7B20C06575-04D4-B545-7264-BEF6F4CD0A7B%7D&siteid=rss&rss=1 | Positive | 0.9997 |
ETD | 2023-10-04T20:15:00.000Z | Ethan Allen Announces Earnings Release Date for its Fiscal 2024 First Quarter Results | https://ml.globenewswire.com/Resource/Download/47330641-d8d8-4170-b2ba-1e8af75a387c | globenewswire | DANBURY, CT, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Ethan Allen Interiors Inc. (“Ethan Allen” or the “Company”) (NYSE: ETD) today announced that it will release its financial and operating results for the fiscal 2024 first quarter ended September 30, 2023, after the market closes on Wednesday, October 25, 2023... | https://www.globenewswire.com/news-release/2023/10/04/2754960/31475/en/Ethan-Allen-Announces-Earnings-Release-Date-for-its-Fiscal-2024-First-Quarter-Results.html | Positive | 0.9169 |
GOVB | 2023-10-04T20:15:00.000Z | Gouverneur Bancorp, Inc. Commences Syndicated Community Offering | globenewswire | GOUVERNEUR, N.Y., Oct. 04, 2023 (GLOBE NEWSWIRE) -- Gouverneur Bancorp, Inc. (“Gouverneur Bancorp”) (OTC Pink Marketplace: GOVB), the holding company for Gouverneur Savings and Loan Association (the “Bank”), announced today that Gouverneur Bancorp, Inc., a newly formed Maryland corporation and the proposed successor holding company of the Bank, has commenced a syndicated community offering to sell the shares of common stock not sold in its subscription and community offerings... | https://www.globenewswire.com/news-release/2023/10/04/2754959/0/en/Gouverneur-Bancorp-Inc-Commences-Syndicated-Community-Offering.html | Positive | 0.9934 |
|
CWT | 2023-10-04T20:15:00.000Z | California Water Service Group Surpasses Global Average ESG Evaluation Score from S&P Global Ratings | https://ml.globenewswire.com/Resource/Download/9eec3db8-2110-4ff2-a2c0-4d92502d0c6c | globenewswire | Group performed on par with other U.S. utility networks, scored higher than the global sector average, and higher than the global average score... | https://www.globenewswire.com/news-release/2023/10/04/2754958/0/en/California-Water-Service-Group-Surpasses-Global-Average-ESG-Evaluation-Score-from-S-P-Global-Ratings.html | Positive | 0.9975 |
FA | 2023-10-04T20:15:00.000Z | First Advantage to Release Third Quarter 2023 Financial Results and Hold Investor Conference Call on November 9, 2023 | https://ml.globenewswire.com/Resource/Download/b6912ede-ebae-4cca-81ad-7b5e724e9373 | globenewswire | ATLANTA, Oct. 04, 2023 (GLOBE NEWSWIRE) -- First Advantage Corporation (NASDAQ: FA), a leading global provider of employment background screening and verification solutions, will issue its third quarter 2023 financial results on Thursday, November 9, 2023 prior to the Company’s earnings conference call, which will be held at 8:30 a.m. ET on the same day... | https://www.globenewswire.com/news-release/2023/10/04/2754957/0/en/First-Advantage-to-Release-Third-Quarter-2023-Financial-Results-and-Hold-Investor-Conference-Call-on-November-9-2023.html | Positive | 0.9869 |
CCI | 2023-10-04T20:15:00.000Z | Crown Castle Announces Third Quarter 2023 Earnings Conference Call Details | https://ml.globenewswire.com/Resource/Download/0e7e143e-5cbc-4415-b7a0-15149bad28b9 | globenewswire | HOUSTON, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Crown Castle Inc. (NYSE: CCI) ("Crown Castle") plans to release its third quarter 2023 results on Wednesday, October 18, 2023, after the market closes. In conjunction with the release, Crown Castle has scheduled a conference call for Thursday, October 19, 2023, at 10:30 a.m. eastern time... | https://www.globenewswire.com/news-release/2023/10/04/2754956/7657/en/Crown-Castle-Announces-Third-Quarter-2023-Earnings-Conference-Call-Details.html | Positive | 0.9118 |
RELL | 2023-10-04T20:15:00.000Z | Richardson Electronics Announces Date of First Quarter Fiscal Year 2024 Conference Call | https://ml.globenewswire.com/Resource/Download/3f990444-bc34-44ad-b41a-1402315b14f2 | globenewswire | LAFOX, Ill., Oct. 04, 2023 (GLOBE NEWSWIRE) -- Richardson Electronics, Ltd. (NASDAQ: RELL) plans to release its financial results for its first quarter ended September 2, 2023 after the close of business on Wednesday, October 11, 2023. The release will be distributed by GlobeNewswire and will be available on the Company’s website at www.rell.com... | https://www.globenewswire.com/news-release/2023/10/04/2754955/0/en/Richardson-Electronics-Announces-Date-of-First-Quarter-Fiscal-Year-2024-Conference-Call.html | Positive | 0.9246 |
COST | 2023-10-04T20:15:00.000Z | Costco Wholesale Corporation Reports September Sales Results | globenewswire | ISSAQUAH, Wash., Oct. 04, 2023 (GLOBE NEWSWIRE) -- Costco Wholesale Corporation (“Costco” or the “Company”) (Nasdaq: COST) today reported net sales of $22.75 billion for the retail month of September, the five weeks ended October 1, 2023, an increase of 6.0 percent from $21.46 billion last year. The five-week period this year included the last week of the 53-week fiscal year 2023 ended September 3, 2023... | https://www.globenewswire.com/news-release/2023/10/04/2754954/0/en/Costco-Wholesale-Corporation-Reports-September-Sales-Results.html | Positive | 0.8422 |
|
HPLT | 2023-10-04T20:10:00.000Z | Heidmar Inc. Announces Termination of Merger Agreement | https://ml.globenewswire.com/Resource/Download/c62fa2f0-5f76-4f93-8412-f5572a1264cb | globenewswire | ATHENS, Greece, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Heidmar Inc. (the “Company”) announced today that it has terminated the Business Combination Agreement dated March 19, 2023 (as amended, the “Business Combination Agreement”) between the Company, Home Plate Acquisition Corporation (NASDAQGM: HPLT), a publicly-listed, special purpose acquisition company (“Home Plate”), Heidmar Marine Inc., Home Plate Sponsor LLC, HP Merger Subsidiary Corp. and certain shareholders of the Company party thereto, p... | https://www.globenewswire.com/news-release/2023/10/04/2754950/0/en/Heidmar-Inc-Announces-Termination-of-Merger-Agreement.html | Positive | 0.9887 |
ALXO | 2023-10-04T20:10:00.000Z | ALX Oncology Announces Proposed Public Offering | https://ml.globenewswire.com/Resource/Download/7a7bdf01-9f0e-4624-9e57-d95403a0dd84 | globenewswire | SOUTH SAN FRANCISCO, Calif., Oct. 04, 2023 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., (“ALX Oncology” or the “Company”) (Nasdaq: ALXO), an immuno-oncology company developing therapies that block the CD47 immune checkpoint pathway, today announced that it has commenced an underwritten public offering of its common stock and pre-funded warrants. All shares of common stock and pre-funded warrants in this offering will be sold by ALX Oncology. The proposed offering is subject to market and ot... | https://www.globenewswire.com/news-release/2023/10/04/2754952/0/en/ALX-Oncology-Announces-Proposed-Public-Offering.html | Positive | 0.8601 |
ODC | 2023-10-04T20:10:00.000Z | Oil-Dri Board of Directors Declares Quarterly Dividends | https://ml.globenewswire.com/Resource/Download/49ea0873-ecd8-4534-8c8d-a89ca3ee8b0a | globenewswire | CHICAGO, Oct. 04, 2023 (GLOBE NEWSWIRE) -- The Board of Directors of Oil-Dri Corporation of America (NYSE: ODC) today declared quarterly cash dividends of $0.29 per share of the Company’s Common Stock and $0.218 per share of the Company’s Class B Stock... | https://www.globenewswire.com/news-release/2023/10/04/2754951/0/en/Oil-Dri-Board-of-Directors-Declares-Quarterly-Dividends.html | Positive | 0.9501 |
CPG | 2023-10-04T20:05:29.000Z | TC Energy successfully completes $5.3 billion sale of a 40 per cent non-controlling equity interest in Columbia Gas and Columbia Gulf | /next-assets/images/schema-image-default.png | benzinga | CALGARY, Alberta, Oct. 04, 2023 (GLOBE NEWSWIRE) -- News Release – TC Energy Corporation ((TSX, NYSE:TRP) (TC Energy or the Company) today announced that it has successfully completed the sale of a 40 per cent non-controlling equity interest in its Columbia Gas Transmission, LLC (Columbia Gas) and Columbia Gulf Transmission, LLC (Columbia Gulf) systems to Global Infrastructure Partners (GIP) for total cash proceeds of $5.3 billion (US$3.9 billion). "This sizable transaction is a tangible exam... | https://www.benzinga.com/pressreleases/23/10/g35096721/tc-energy-successfully-completes-5-3-billion-sale-of-a-40-per-cent-non-controlling-equity-interest | Positive | 0.9814 |
HHS | 2023-10-04T20:05:21.000Z | Gritstone bio Announces Presentations from Phase 1 Studies Evaluating Next-Generation Vaccine Candidate for COVID-19 at IDWeek 2023 | /next-assets/images/schema-image-default.png | benzinga | EMERYVILLE, Calif., Oct. 04, 2023 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (NASDAQ:GRTS), a clinical-stage biotechnology company working to develop the world's most potent vaccines, today announced results from all three (3) Phase 1 studies evaluating its self-amplifying mRNA (samRNA) vaccine candidates against COVID-19 (part of the company's CORAL program) are to be presented at IDWeek 2023, occurring October 11-15, 2023, in Boston, MA. Last week, Gritstone bio announced a contract with the B... | https://www.benzinga.com/pressreleases/23/10/g35096718/gritstone-bio-announces-presentations-from-phase-1-studies-evaluating-next-generation-vaccine-cand | Positive | 0.9892 |
ON | 2023-10-04T20:05:07.000Z | Revolution Medicines to Present New Clinical Data at Major Oncology Conferences and Host Investor Webcast | /next-assets/images/schema-image-default.png | benzinga | Interim Data to be Presented for RMC-6236 (RASMULTI(ON) Inhibitor) and RMC-6291 (RASG12C(ON) Inhibitor) Company to Host Investor Webcast Following ESMO Data Presentation on October 22 at 12:30 p.m. Eastern REDWOOD CITY, Calif., Oct. 04, 2023 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (NASDAQ:RVMD), a clinical-stage oncology company developing targeted therapies for RAS-addicted cancers, today announced the company will present new clinical data for two of its RAS(ON) Inhibitors and other... | https://www.benzinga.com/pressreleases/23/10/g35096712/revolution-medicines-to-present-new-clinical-data-at-major-oncology-conferences-and-host-investor- | Positive | 0.9117 |
PHXM | 2023-10-04T20:05:00.000Z | PHAXIAM Receives Compliance Notice from Nasdaq | https://ml-eu.globenewswire.com/Resource/Download/a0718b1d-a228-44cf-9879-936caaba20fa | globenewswire | PHAXIAM Receives Compliance Notice from Nasdaq... | https://www.globenewswire.com/news-release/2023/10/04/2754943/0/en/PHAXIAM-Receives-Compliance-Notice-from-Nasdaq.html | Positive | 0.9424 |
SLNO | 2023-10-04T20:05:00.000Z | Soleno Therapeutics Announces DCCR Data Presentation at the Foundation for Prader-Willi Research Symposium | https://ml.globenewswire.com/Resource/Download/1b6ad7f8-f61c-45d6-8b8d-9bc78be2f8b6 | globenewswire | REDWOOD CITY, Calif., Oct. 04, 2023 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno or the Company) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced an oral presentation at the Foundation for Prader-Willi Research (FPWR) 2023 Research Symposium, being held October 5-6, 2023, in Denver, Colorado. The presentation features results from the recently completed randomized withdrawal period of Study C60... | https://www.globenewswire.com/news-release/2023/10/04/2754941/0/en/Soleno-Therapeutics-Announces-DCCR-Data-Presentation-at-the-Foundation-for-Prader-Willi-Research-Symposium.html | Positive | 0.8832 |
KRON | 2023-10-04T20:05:00.000Z | Kronos Bio To Present Interim Data from Phase 1 Dose Escalation Portion of Ongoing Phase 1/2 KB-0742 Study at AACR-NCI-EORTC and Host Virtual Investor Event on October 13 | https://ml.globenewswire.com/Resource/Download/1ca8d278-9167-4b71-9fb1-e39763e61149 | globenewswire | Management to host conference call and webcast on October 13 at 4:30 PM ET with key opinion leader and KB-0742 trial investigator, Miguel Villalona-Calero, M.D., of City of Hope Management to host conference call and webcast on October 13 at 4:30 PM ET with key opinion leader and KB-0742 trial investigator, Miguel Villalona-Calero, M.D., of City of Hope... | https://www.globenewswire.com/news-release/2023/10/04/2754940/0/en/Kronos-Bio-To-Present-Interim-Data-from-Phase-1-Dose-Escalation-Portion-of-Ongoing-Phase-1-2-KB-0742-Study-at-AACR-NCI-EORTC-and-Host-Virtual-Investor-Event-on-October-13.html | Positive | 0.4588 |
GNSS | 2023-10-04T20:05:00.000Z | Genasys Announces Closing of $10 Million Public Offering of Common Stock | https://ml.globenewswire.com/Resource/Download/8190d298-885e-4c9d-a608-24487b9bbbaa | globenewswire | SAN DIEGO, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Genasys Inc. (“Genasys” or the “Company”) (Nasdaq: GNSS), the leader in Protective Communications solutions, today announced the closing of its previously announced underwritten public offering of 5,750,000 shares of its common stock at a public offering price of $2.00 per share of common stock, which includes the full exercise of the underwriters’ option to purchase 750,000 additional shares of common stock to cover over-allotments. The Company rec... | https://www.globenewswire.com/news-release/2023/10/04/2754939/24431/en/Genasys-Announces-Closing-of-10-Million-Public-Offering-of-Common-Stock.html | Positive | 0.9768 |
GNSS | 2023-10-04T20:05:00.000Z | Genasys Completes Acquisition of Evertel | https://ml.globenewswire.com/Resource/Download/8190d298-885e-4c9d-a608-24487b9bbbaa | globenewswire | Genasys and Evertel Strengthen Protective Communications with Enhanced Agency Collaboration Genasys and Evertel Strengthen Protective Communications with Enhanced Agency Collaboration... | https://www.globenewswire.com/news-release/2023/10/04/2754938/24431/en/Genasys-Completes-Acquisition-of-Evertel.html | Positive | 0.9905 |
ZYNE | 2023-10-04T20:05:00.000Z | Important Information for Zynerba Pharmaceuticals Stockholders to Tender Shares for the Harmony Transaction: Process and Instructions | https://ml.globenewswire.com/Resource/Download/8808ec02-5a09-4421-b36b-f47b1f479f29 | globenewswire | DEVON, Pa., Oct. 04, 2023 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for orphan neuropsychiatric disorders, today reminds all stockholders, including individual stockholders, to promptly tender their shares into the tender offer (the “Offer”) by Harmony Biosciences Holdings, Inc. (“Harmony”) and its wholly owned subsidiary, Xylophone Acquisition Corp. (“Purchaser”), to purchase all outst... | https://www.globenewswire.com/news-release/2023/10/04/2754937/36775/en/Important-Information-for-Zynerba-Pharmaceuticals-Stockholders-to-Tender-Shares-for-the-Harmony-Transaction-Process-and-Instructions.html | Positive | 0.9991 |
PI | 2023-10-04T20:05:00.000Z | IR-MED Appoints Healthcare Executive and Entrepreneur Tzur Di-Cori as Chief Executive Officer | https://ml.globenewswire.com/Resource/Download/b123fcc6-bdae-4fd2-8b69-d6b499c0ea02 | globenewswire | Mr. Di-Cori’s vast healthcare experience includes President of LifeWatch Technologies, a developer of technologies that help physicians detect symptoms before they become major health problems... | https://www.globenewswire.com/news-release/2023/10/04/2754936/0/en/IR-MED-Appoints-Healthcare-Executive-and-Entrepreneur-Tzur-Di-Cori-as-Chief-Executive-Officer.html | Positive | 0.9743 |
SB | 2023-10-04T20:05:00.000Z | Safe Bulkers, Inc. Declares Quarterly Dividend on its 8.00% Series C Cumulative Redeemable Perpetual Preferred Shares; 8.00% Series D Cumulative Redeemable Perpetual Preferred Shares | https://ml.globenewswire.com/Resource/Download/8e21edb4-c875-475e-abd5-10f55f69335b | globenewswire | MONACO, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Safe Bulkers, Inc. (the “Company”) (NYSE: SB), an international provider of marine drybulk transportation services, announced today that the Company's Board of Directors has declared:... | https://www.globenewswire.com/news-release/2023/10/04/2754935/0/en/Safe-Bulkers-Inc-Declares-Quarterly-Dividend-on-its-8-00-Series-C-Cumulative-Redeemable-Perpetual-Preferred-Shares-8-00-Series-D-Cumulative-Redeemable-Perpetual-Preferred-Shares.html | Positive | 0.9836 |
MXCT | 2023-10-04T20:05:00.000Z | MaxCyte Announces Preliminary Third Quarter 2023 Revenue and Updates Full Year 2023 Revenue Guidance | https://ml.globenewswire.com/Resource/Download/8f0f0d48-fc4f-4d03-ac70-f4d096a780bd | globenewswire | ROCKVILLE, Md., Oct. 04, 2023 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and innovative bioprocessing, today announced preliminary revenue for the third quarter ended September 30, 2023 and updated its full year 2023 revenue guidance... | https://www.globenewswire.com/news-release/2023/10/04/2754934/0/en/MaxCyte-Announces-Preliminary-Third-Quarter-2023-Revenue-and-Updates-Full-Year-2023-Revenue-Guidance.html | Positive | 0.9909 |
ESGL | 2023-10-04T20:05:00.000Z | ESGL Holdings Limited Reports First Half 2023 Results | https://ml.globenewswire.com/Resource/Download/df293bfe-9d33-4db8-9828-56c9659f59df | globenewswire | ESGL Holdings Limited Reports First Half 2023 Results 1H revenues increase by 14.1% to $3.4 million 1H +6.3% gross margin expansion vs last year... | https://www.globenewswire.com/news-release/2023/10/04/2754933/0/en/ESGL-Holdings-Limited-Reports-First-Half-2023-Results.html | Positive | 0.9992 |
ACCD | 2023-10-04T20:05:00.000Z | Accolade Announces Results for Fiscal Second Quarter 2024 | https://ml.globenewswire.com/Resource/Download/7f7f1841-5c76-4913-98e7-b40837ca349b | globenewswire | SEATTLE, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced financial results for the fiscal second quarter ended August 31, 2023... | https://www.globenewswire.com/news-release/2023/10/04/2754932/0/en/Accolade-Announces-Results-for-Fiscal-Second-Quarter-2024.html | Positive | 0.9984 |
MS | 2023-10-04T20:05:00.000Z | Neuer QuantiFERON-EBV RUO-Test von QIAGEN unterstützt Erforschung der zellvermittelten Immunreaktion auf Epstein‑Barr‑Virus | https://ml.globenewswire.com/Resource/Download/141526b5-4f4b-48ed-bf23-2d8dcec9e546 | globenewswire | QuantiFERON-EBV RUO ermöglicht dynamische Sicht auf Immunreaktion des Wirts und soll Forschern helfen, Epstein-Barr-Virus-Infektionen und damit verbundene bösartige Erkrankungen zu verstehen // Treibt Forschung zu onkologischen und Autoimmunerkrankungen durch Messung der T-Zell-Reaktionen auf EBV an und bietet Einblicke in Bedeutung der Viren bei diesen Erkrankungen // Portfolio an QuantiFERON-Tests zur Messung der zellvermittelten Immunreaktion über Tuberkulose hinaus erweitert... | https://www.globenewswire.com/news-release/2023/10/04/2754931/0/de/Neuer-QuantiFERON-EBV-RUO-Test-von-QIAGEN-unterst%C3%BCtzt-Erforschung-der-zellvermittelten-Immunreaktion-auf-Epstein-Barr-Virus.html | Negative | -0.9991 |
IMRX | 2023-10-04T20:05:00.000Z | Immuneering to Present Preclinical Data on IMM-1-104 and IMM-6-415 at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics | https://ml.globenewswire.com/Resource/Download/53f47482-3967-413c-b106-7062bb5140f7 | globenewswire | CAMBRIDGE, Mass., Oct. 04, 2023 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company developing medicines for broad populations of cancer patients with an initial aim to develop a universal-RAS therapy, today announced that it will present preclinical data on IMM-1-104, its lead clinical-stage program, and IMM-6-415 at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, being held October 11-15, 2023 in Boston... | https://www.globenewswire.com/news-release/2023/10/04/2754930/0/en/Immuneering-to-Present-Preclinical-Data-on-IMM-1-104-and-IMM-6-415-at-AACR-NCI-EORTC-International-Conference-on-Molecular-Targets-and-Cancer-Therapeutics.html | Negative | -0.9075 |
MS | 2023-10-04T20:05:00.000Z | QIAGEN launches QuantiFERON-EBV RUO assay, facilitating research of cell-mediated immune response to Epstein-Barr virus | https://ml.globenewswire.com/Resource/Download/246e7219-f67c-4364-bb7d-5085c4436a49 | globenewswire | QuantiFERON-EBV RUO to help researchers understand Epstein-Barr virus (EBV) infections and related malignancies, offering a dynamic view of the host immune response // Advancing research in oncology and autoimmune diseases through measurement of T-cell responses to EBV, providing valuable insights into the virus’ role in these conditions // Further expanding portfolio of QuantiFERON cell-mediated immune response tests beyond tuberculosis QuantiFERON-EBV RUO to help researchers understand Epstein... | https://www.globenewswire.com/news-release/2023/10/04/2754929/8690/en/QIAGEN-launches-QuantiFERON-EBV-RUO-assay-facilitating-research-of-cell-mediated-immune-response-to-Epstein-Barr-virus.html | Positive | 0.9977 |
ON | 2023-10-04T20:05:00.000Z | Revolution Medicines to Present New Clinical Data at Major Oncology Conferences and Host Investor Webcast | https://ml.globenewswire.com/Resource/Download/11b9b98e-0ef7-4a2e-8bba-71e7bde12cad | globenewswire | Interim Data to be Presented for RMC-6236 (RASMULTI(ON) Inhibitor) and RMC-6291 (RASG12C(ON) Inhibitor)... | https://www.globenewswire.com/news-release/2023/10/04/2754945/0/en/Revolution-Medicines-to-Present-New-Clinical-Data-at-Major-Oncology-Conferences-and-Host-Investor-Webcast.html | Positive | 0.909 |
GRTS | 2023-10-04T20:05:00.000Z | Gritstone bio Announces Presentations from Phase 1 Studies Evaluating Next-Generation Vaccine Candidate for COVID-19 at IDWeek 2023 | https://ml.globenewswire.com/Resource/Download/10ab3b46-ba2d-4eb9-a055-e0a5b8c7d953 | globenewswire | EMERYVILLE, Calif., Oct. 04, 2023 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop the world’s most potent vaccines, today announced results from all three (3) Phase 1 studies evaluating its self-amplifying mRNA (samRNA) vaccine candidates against COVID-19 (part of the company’s CORAL program) are to be presented at IDWeek 2023, occurring October 11-15, 2023, in Boston, MA. Last week, Gritstone bio announced a contract with the B... | https://www.globenewswire.com/news-release/2023/10/04/2754942/0/en/Gritstone-bio-Announces-Presentations-from-Phase-1-Studies-Evaluating-Next-Generation-Vaccine-Candidate-for-COVID-19-at-IDWeek-2023.html | Positive | 0.9892 |
CPG | 2023-10-04T20:05:00.000Z | TC Energy successfully completes $5.3 billion sale of a 40 per cent non-controlling equity interest in Columbia Gas and Columbia Gulf | https://ml.globenewswire.com/Resource/Download/c05c8c3b-12a9-4ce9-ba6f-0cb790d639b9 | globenewswire | Proceeds from transaction significantly accelerate deleveraging and deliver key 2023 strategic priority Proceeds from transaction significantly accelerate deleveraging and deliver key 2023 strategic priority... | https://www.globenewswire.com/news-release/2023/10/04/2754946/0/en/TC-Energy-successfully-completes-5-3-billion-sale-of-a-40-per-cent-non-controlling-equity-interest-in-Columbia-Gas-and-Columbia-Gulf.html | Positive | 0.9843 |
QCRH | 2023-10-04T20:05:00.000Z | QCR Holdings, Inc. to Report Third Quarter 2023 Financial Results | https://ml.globenewswire.com/Resource/Download/6d475ef0-eb7c-4f3e-89d8-1d6d5ef5fb11 | globenewswire | MOLINE, Ill., Oct. 04, 2023 (GLOBE NEWSWIRE) -- QCR Holdings, Inc. (NASDAQ: QCRH) announced today that its third quarter ended September 30, 2023, financial results will be released after the market closes on Wednesday, October 25, 2023. The Company will host a conference call and webcast the next day, Thursday, October 26, 2023, at 10:00 a.m. Central Time to discuss the results. Shareholders, analysts, and other interested parties are invited to join... | https://www.globenewswire.com/news-release/2023/10/04/2754948/9114/en/QCR-Holdings-Inc-to-Report-Third-Quarter-2023-Financial-Results.html | Positive | 0.9849 |
INBS | 2023-10-04T20:05:00.000Z | Intelligent Bio Solutions Inc. Announces Closing of $4.378 Million Underwritten Public Offering Including Partial Exercise of Underwriters’ Overallotment Option | https://ml.globenewswire.com/Resource/Download/a26556cb-e019-4223-91c3-509ef513d51d | globenewswire | NEW YORK, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the closing of its previously announced underwritten public offering of units (the “Units”) for gross proceeds of approximately $4.378 million prior to deducting underwriting discounts and commissions and offering expenses, including partial exercise of the underwriter’s over-allotm... | https://www.globenewswire.com/news-release/2023/10/04/2754947/0/en/Intelligent-Bio-Solutions-Inc-Announces-Closing-of-4-378-Million-Underwritten-Public-Offering-Including-Partial-Exercise-of-Underwriters-Overallotment-Option.html | Positive | 0.9987 |
GRBK | 2023-10-04T20:05:00.000Z | Green Brick Partners, Inc. Announces New Land Acquisition in Vero Beach, FL | https://ml.globenewswire.com/Resource/Download/b1ff57a7-76d0-402b-b807-67ed82c6509f | globenewswire | PLANO, Texas, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Green Brick Partners, Inc. (NYSE: GRBK) (the “Company” or “Green Brick”), one of Fortune Magazine’s fastest growing companies in 2022 and its fastest growing public homebuilder, announced that the Company has purchased 78 homes sites in Grand Harbor, a longstanding master-planned community in Vero Beach known for its beautiful waterfront homes and golf courses. Vero Beach is about 80 miles north of Palm Beach, FL and is an important city in the T... | https://www.globenewswire.com/news-release/2023/10/04/2754949/0/en/Green-Brick-Partners-Inc-Announces-New-Land-Acquisition-in-Vero-Beach-FL.html | Positive | 0.9968 |
PWS | 2023-10-04T20:05:00.000Z | Soleno Therapeutics Announces DCCR Data Presentation at the Foundation for Prader-Willi Research Symposium | /next-assets/images/schema-image-default.png | benzinga | REDWOOD CITY, Calif., Oct. 04, 2023 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno or the Company) (NASDAQ:SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced an oral presentation at the Foundation for Prader-Willi Research (FPWR) 2023 Research Symposium, being held October 5-6, 2023, in Denver, Colorado. The presentation features results from the recently completed randomized withdrawal period of Study C60... | https://www.benzinga.com/pressreleases/23/10/g35096680/soleno-therapeutics-announces-dccr-data-presentation-at-the-foundation-for-prader-willi-research-s | Positive | 0.903 |
ZYNE | 2023-10-04T20:05:00.000Z | Important Information for Zynerba Pharmaceuticals Stockholders to Tender Shares for the Harmony Transaction: Process and Instructions | /next-assets/images/schema-image-default.png | benzinga | DEVON, Pa., Oct. 04, 2023 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for orphan neuropsychiatric disorders, today reminds all stockholders, including individual stockholders, to promptly tender their shares into the tender offer (the "Offer") by Harmony Biosciences Holdings, Inc. ("Harmony") and its wholly owned subsidiary, Xylophone Acquisition Corp. ("Purchaser"), to purchase all outst... | https://www.benzinga.com/pressreleases/23/10/g35096685/important-information-for-zynerba-pharmaceuticals-stockholders-to-tender-shares-for-the-harmony-tr | Positive | 0.999 |
PHXM | 2023-10-04T20:05:00.000Z | PHAXIAM Receives Compliance Notice from Nasdaq | /next-assets/images/schema-image-default.png | benzinga | PHAXIAM Receives Compliance Notice from Nasdaq Lyon (France) et Cambridge (MA, US), October 4, 2023, at 10:05 pm CEST – PHAXIAM Therapeutics (Nasdaq & Euronext: PHXM), today announced that it has received confirmation from Nasdaq that it has regained compliance with Listing Rule 5550(a)(2). With closing bid price of PHAXIAM's American Depositary Shares ("ADSs") above $1.00 per ADS for the 10 consecutive business days from September 18 through September 29, 2023, PHAXIAM has regained compliance... | https://www.benzinga.com/pressreleases/23/10/g35096688/phaxiam-receives-compliance-notice-from-nasdaq | Positive | 0.9424 |
TSLA | 2023-10-04T20:03:20.000Z | Tesla Stock Flashes Aggressive Buy Signal, Leading S&P 500, As Bulls Shrug Off Bad News | https://media.zenfs.com/en/ibd.com/f78b10a7008c3190c32794eacefb154b | finance | Tesla (TSLA) appeared to shake off any lingering investor concern over its third-quarter delivery miss earlier in the week, with TSLA shares powering above a key level, leading the S&P 500 Wednesday. X With Tesla bulls betting on a fourth-quarter rebound in deliveries with the revamped Model 3 in China and the expected Cybertruck delivery launch, Tesla stock surged 5.9% to 261.16 Wednesday during market action. However, analysts are also cutting third-quarter EPS estimates ahead of Tesla's Q | https://www.investors.com/news/tesla-stock-flashes-buy-signal-leads-sp-500-bulls-shrug-off-bad-news/?src=A00220&yptr=yahoo | Positive | 0.9658 |
CVX | 2023-10-04T20:02:48.000Z | Energy Stocks Slide As Gasoline Futures Sink Near Year Lows After Key EIA Data | https://media.zenfs.com/en/ibd.com/551a898e5d7504fa02a3f4dee7d103a8 | finance | U.S. oil prices and energy stocks, including ExxonMobil (XOM) along with Warren Buffett-backed Chevron (CVX) and Occidental Petroleum (OXY), fell Wednesday as the Energy Information Administration's (EIA) reported crude oil inventories decreased by more than 2 million barrels last week, but swelling gasoline stockpiles. X West Texas Intermediate (WTI) oil prices slipped 4.6% to $84.60 per barrel Wednesday, after hitting $93 per barrel last week. The EIA announced Wednesday morning that U.S. | https://www.investors.com/news/exxonmobil-stock-oil-prices-slide-eia-data-gasoline-demand-in-focus/?src=A00220&yptr=yahoo | Negative | -0.9169 |
XOM | 2023-10-04T20:02:48.000Z | Energy Stocks Slide As Gasoline Futures Sink Near Year Lows After Key EIA Data | https://media.zenfs.com/en/ibd.com/551a898e5d7504fa02a3f4dee7d103a8 | finance | U.S. oil prices and energy stocks, including ExxonMobil (XOM) along with Warren Buffett-backed Chevron (CVX) and Occidental Petroleum (OXY), fell Wednesday as the Energy Information Administration's (EIA) reported crude oil inventories decreased by more than 2 million barrels last week, but swelling gasoline stockpiles. X West Texas Intermediate (WTI) oil prices slipped 4.6% to $84.60 per barrel Wednesday, after hitting $93 per barrel last week. The EIA announced Wednesday morning that U.S. | https://www.investors.com/news/exxonmobil-stock-oil-prices-slide-eia-data-gasoline-demand-in-focus/?src=A00220&yptr=yahoo | Negative | -0.9337 |
LNG | 2023-10-04T19:45:00.000Z | Why Utility Stocks Could Be a Contrarian Safeguard Amid Growing Rates | fool | Utility stocks look oversold right now. The post Why Utility Stocks Could Be a Contrarian Safeguard Amid Growing Rates appeared first on The Motley Fool Canada... | https://www.fool.ca/2023/10/04/why-utility-stocks-could-be-a-contrarian-safeguard-amid-growing-rates/ | Positive | 0.9985 |
|
GBUX | 2023-10-04T19:35:00.000Z | GivBux Appoints Atlanta Capital Partners, LLC for Investor Relations | https://ml.globenewswire.com/Resource/Download/7dd32e88-7bde-42dd-b7ed-ddfd62f64f58 | globenewswire | NEWPORT BEACH, Calif., Oct. 04, 2023 (GLOBE NEWSWIRE) -- GivBux Inc. (OTC: GBUX), developers of the GivBux Super App, a multifaceted platform simplifying shopping and fostering a culture of giving, today announces it has engaged Atlanta Capital Partners, LLC for comprehensive investor relations services. This initiative aims at enhancing market awareness and fostering deeper engagement within the investor community. Atlanta Capital Partners specializes in facilitating communication between pub... | https://www.globenewswire.com/news-release/2023/10/04/2754919/0/en/GivBux-Appoints-Atlanta-Capital-Partners-LLC-for-Investor-Relations.html | Positive | 0.9991 |
DAL | 2023-10-04T19:24:15.000Z | Delta Air Lines 3Q23 Earnings In Focus: BofA Securities Expects No Surprises And Highlights Cost Pressure | benzinga | BofA Securities analyst Andrew G. Didora reiterated a Buy rating on the shares of Delta Air Lines Inc (NYSE: DAL) with a price target of $50. DAL is slated to report third-quarter FY23 earnings on October 12. The analyst is not expecting any surprises in 3Q23 results given the company updated current trends in mid-September. The analyst now sees $1.00 in 4Q23 EPS (from $1.09 prior) as cost pressures remain more acute than previously expected. The key focus ...Full story available on Benzinga.com... | https://www.benzinga.com/analyst-ratings/analyst-color/23/10/35094507/delta-air-lines-3q23-earnings-in-focus-bofa-securities-expects-no-surprises-and-hig | Positive | 0.9191 |
|
NFLX | 2023-10-04T19:23:46.000Z | Netflix's Price Hike Is A Risky Move During Economic Uncertainty, Analyst Says | benzinga | Benchmark analyst Matthew Harrigan reiterated Netflix Inc (NASDAQ: NFLX) with a Sell and a $325 price target. A Tuesday report indicated that Netflix will increase prices starting in North America for its SVOD offerings – an indicator of both mirroring pricing actions from its near peers and that lower price point to consumer AVOD economics can be significantly accretive relative to SVOD. It provides a positive cross-read for competing services like Peacock and Max, emphasizing AVOD and featuri... | https://www.benzinga.com/news/23/10/35093164/netflixs-price-hike-is-a-risky-move-during-economic-uncertainty-analyst-says | Positive | 0.9424 |
|
NVAX | 2023-10-04T19:19:24.000Z | Novavax's COVID-19 Shot Just In Time, Optimism Surrounds As Demand Picks Up Momentum | benzinga | Tuesday, the FDA granted an emergency use nod to Novavax Inc's (NASDAQ: NVAX) COVID-19 Vaccine, Adjuvanted (2023-2024 Formula) (NVX-CoV2601) for active immunization to prevent COVID-19 in individuals aged 12 and older. B. Riley says today's authorization comes timely as the Street's bearish perception of overall COVID-19 vaccine demand. The pace of COVID-19 hospitalizations and emergency room visits has recently moderated after an initial spike in late August. B. Riley says that growing awarene... | https://www.benzinga.com/analyst-ratings/analyst-color/23/10/35094037/novavaxs-covid-19-shot-just-in-time-optimism-surrounds-as-demand-picks-up-momentum | Positive | 0.6494 |
|
FNGR | 2023-10-04T19:18:33.000Z | What's Going On With FingerMotion Stock Today? | benzinga | FingerMotion, Inc. (NASDAQ: FNGR) shares are trading higher on Wednesday. The company responded to a short seller report issued by Capybara Research. What To Know: Capybara Research issued a short seller report on FingerMotion on Oct. 3. The company's management team reviewed the report and described it as containing, "many errors, unsupported speculations and inaccurate ...Full story available on Benzinga.com... | https://www.benzinga.com/news/23/10/35095568/whats-going-on-with-fingermotion-stock-today | Positive | 0.8934 |
|
BAC | 2023-10-04T19:16:57.000Z | What's Going On With Bank Of America Stock? | benzinga | Bank Of America Corp (NYSE: BAC) shares are trading lower Wednesday, adding to losses of more than 6% over the last week. Here's a look at what's going on. What To Know: Bank of America shares have come under pressure in recent trading sessions alongside the broader market as Treasury yields continue to climb. Investors are grappling with the possibility that interest rates will remain higher for longer and are trying to decide how to position their portfolios. Rising treasury yields is usuall... | https://www.benzinga.com/news/23/10/35095561/whats-going-on-with-bank-of-america-stock | Positive | 0.8741 |
|
BLK | 2023-10-04T19:10:21.000Z | Former BlackRock Insider Foresees Bitcoin ETF Green Light By SEC Within Months | benzinga | Steven Schoenfield, former managing director at BlackRock (NYSE: BLK) and current CEO of MarketVector Indexes, anticipates the Securities and Exchange Commission (SEC) will greenlight a Bitcoin (CRYPTO: BTC) spot ETF within "three to six months." This prediction was shared during a panel on ETFs at CCData’s Digital Asset Summit in London, Decrypt reported. Schoenfield's remarks came in response to Martin Bednall, another ex-BlackRock director and now CEO of Jacobi Asset Management, who opined,... | https://www.benzinga.com/markets/cryptocurrency/23/10/35094518/former-blackrock-insider-foresees-bitcoin-etf-green-light-by-sec-within-months | Positive | 0.9913 |
|
CD | 2023-10-04T19:02:57.000Z | How to find out your 2024 Social Security COLA increase | https://s.yimg.com/os/creatr-uploaded-images/2023-10/f97b38f0-62e1-11ee-be2f-0000d757910a | finance | Ponomariova_Maria via Getty ImagesIn a few weeks, the Social Security Administration will announce its annual cost of living adjustment for 2024. Based on inflation data and other economic indicators, experts estimate the 2024 Social Security COLA will be around 3.2%, or roughly $58 a month for the average retiree. Here’s how you can find out early how much more you’ll see in your own check. | https://finance.yahoo.com/personal-finance/social-security-2024-cola-increase-184950417.html | Positive | 0.9973 |
DAL | 2023-10-04T19:01:17.000Z | Oil: 'Demand destruction has begun', say JPMorgan analysts | https://s.yimg.com/os/creatr-uploaded-images/2023-09/e1194170-612f-11ee-bbd7-d049eb580908 | finance | Oil rallied an average of 28% last quarter, jumping to a 2023 high in September, as OPEC+ output cuts and further supply restraints from Saudi Arabia and Russia created a deficit in the market. Expect crude demand to decline this quarter following the recent rally, JPMorgan analysts said in a recent client note". After reaching our target of $90 in September, our end-year target remains $86 [per barrel]," wrote Natasha Kaneva, head of the global commodities strategy team at JPMorgan. | https://finance.yahoo.com/news/oil-demand-destruction-has-begun-say-jpmorgan-analysts-151912451.html | Negative | -0.9549 |
AAL | 2023-10-04T19:01:17.000Z | Oil: 'Demand destruction has begun', say JPMorgan analysts | https://s.yimg.com/os/creatr-uploaded-images/2023-09/e1194170-612f-11ee-bbd7-d049eb580908 | finance | Oil rallied an average of 28% last quarter, jumping to a 2023 high in September as OPEC+ output cuts and further supply restraints from Saudi Arabia and Russia created a deficit in the market. Expect crude demand to decline this quarter following the recent rally, JPMorgan analysts said in a recent client note". After reaching our target of $90 in September, our end-year target remains $86 [per barrel]," wrote Natasha Kaneva, head of the global commodities strategy team at JPMorgan. | https://finance.yahoo.com/news/oil-demand-destruction-has-begun-say-jpmorgan-analysts-151912451.html | Negative | -0.9549 |
IP | 2023-10-04T18:53:00.000Z | IPO Report: Birkenstock’s valuation is too high and investors may not make money in its IPO, analyst says | https://images.mktw.net/im-862629?width=700&height=466 | marketwatch | After lackluster deals from Arm Holdings and Instacart, investors should rethink IPO valuations, says David Trainer... | http://www.marketwatch.com/news/story.asp?guid=%7B20C06575-04D4-B545-7275-88E639E1DFDC%7D&siteid=rss&rss=1 | Positive | 0.9926 |
HD | 2023-10-04T18:44:38.000Z | Home Depot Poised For Long-Term Win In Retail Despite Current Macro Challenges: Analyst | benzinga | Telsey Advisory Group analyst Joseph Feldman reiterated the Market Perform rating on Home Depot, Inc. (NYSE: HD), lowering the price target to $330 from $335. Feldman lowered 3Q23 and annual estimates for Home Depot owing to higher interest, inflation, and other macro factors that have intensified and beyond anticipation since the end of August. Home price appreciation is slowing, and real disposable income has been under pressure due to inflation and higher interest rates—both of which histori... | https://www.benzinga.com/analyst-ratings/analyst-color/23/10/35094256/home-depot-poised-for-long-term-win-in-retail-despite-current-macro-challenges-anal | Positive | 0.91 |
|
NAV | 2023-10-04T18:43:00.000Z | Canadian General Investments: Investment Update - Unaudited | https://ml.globenewswire.com/Resource/Download/074a69e6-8b82-4b06-8a56-cb23a100fdaa | globenewswire | TORONTO, Canada, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Canadian General Investments, Limited (CGI) (TSX: CGI) (LSE: CGI) reports on an unaudited basis that its net asset value per share (NAV) at September 30, 2023 was $54.29, resulting in year-to-date and 12-month NAV returns, with dividends reinvested, of 14.0% and 22.1%, respectively. These compare with the 3.4% and 9.5% returns of the benchmark S&P/TSX Composite Index on a total return basis for the same periods... | https://www.globenewswire.com/news-release/2023/10/04/2754909/0/en/Canadian-General-Investments-Investment-Update-Unaudited.html | Positive | 0.9512 |
RUN | 2023-10-04T18:41:41.000Z | Residential Solar Market Struggles: Analyst Highlights Policy Shifts And Rates Curbing US Growth | benzinga | Truist Securities analyst Jordan Levy cut the rating and price target of several Sustainability equities following the recent broad-based sell-off on increased investor concerns amid a 'higher-for-longer' rate environment. The analyst downgraded Sunrun Inc (NASDAQ: RUN) to Hold from Buy and lowered its price target to $12 from $30. Levy lowered the rating on Sunnova Energy International, Inc (NYSE: NOVA) to Hold from Buy at a decreased price target of $11 from $35. On the other hand, the analyst... | https://www.benzinga.com/analyst-ratings/analyst-color/23/10/35094190/residential-solar-market-struggles-analyst-highlights-policy-shifts-and-rates-curbi | Positive | 0.9652 |
|
SPOT | 2023-10-04T18:36:48.000Z | Morgan Stanley Says Spotify's Foray Into Audiobooks Could Lower Churn And Increase Pricing Power | benzinga | Morgan Stanley analyst Benjamin Swinburne maintained an Overweight rating on the shares of Spotify Technology SA (NYSE: SPOT) with a price target of $185. Spotify announced that it is more formally entering the audiobooks market, starting with the U.K. and Australia, with other parts of the world following soon. Today, the offer will include 15 hours of free listening for Premium subscribers with participation from all major book publishers and independents. Related: Spotify Takes On Amazon's Au... | https://www.benzinga.com/analyst-ratings/analyst-color/23/10/35093697/morgan-stanley-says-spotifys-foray-into-audiobooks-could-lower-churn-and-increase-p | Positive | 0.9348 |
|
BAC | 2023-10-04T18:31:36.000Z | When Will the Fed Stop Rate Hikes? Dimon, Ackman, Dalio May Have Reached a Consensus | https://media.zenfs.com/en/observer_419/d97608429efb1431d4d421185d7c7cac | finance | Bank CEOs and hedge fund moguls are expecting interest rates to stay high for the foreseeable future. Getty Images/ObserverIn a bid to fight soaring inflation, the Federal Reserve has increased the federal funds rate 11 times since March 2022 to its highest level since 2001. A benchmark determining the interest rates of mortgages, credit cards and other types of loans, the federal funds rate also affects the yields of government bonds such as the 30-year and 10-year Treasury bills. | https://finance.yahoo.com/news/fed-stop-rate-hikes-dimon-183136108.html | Positive | 0.9955 |
ZM | 2023-10-04T18:21:10.000Z | Zoom's AI Companion Free For Paid Users, While Competitors Charge $30-$50 Per Seat: Analyst Weighs In | benzinga | Stifel analyst J. Parker Lane reiterated a Hold rating on Zoom Video Communications, Inc. (NASDAQ: ZM), lowering the price target to $70 from $75. Lane writes Zoom's decision to include AI Companion at no additional cost for paid users is notable given that competitors charge $30-$50 per seat for similar offerings, the analyst highlights. Zoom did not provide financial updates for the quarter or the full year during the Investor Q&A at the Zoomtopia conference in San Jose, including the progress... | https://www.benzinga.com/analyst-ratings/analyst-color/23/10/35093811/zooms-ai-companion-free-for-paid-users-while-competitors-charge-30-50-per-seat-anal | Positive | 0.9774 |
|
IART | 2023-10-04T18:18:16.000Z | Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of Integra LifeSciences Holdings Corporation (IART) Investors and Encourages Investors to Contact the Firm Before November 13, 2023 | /next-assets/images/schema-image-default.png | benzinga | NEW YORK, Oct. 04, 2023 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the District of New Jersey on behalf of those who acquired Integra LifeSciences Holdings Corporation ("Integra" or the "Company") (NASDAQ:IART) securities during the period from March 11, 2019 through May 22, 2023 (the "Class Period"). Investors have until November 13, 2023 to apply to the Court to be appointed as lead plaintiff in... | https://www.benzinga.com/pressreleases/23/10/g35095073/kirby-mcinerney-llp-reminds-investors-that-a-class-action-lawsuit-has-been-filed-on-behalf-of-inte | Positive | 0.9705 |
NCA | 2023-10-04T18:17:56.000Z | National Cybersecurity Alliance Kicks Off 20th Annual Cybersecurity Awareness Month | /next-assets/images/schema-image-default.png | benzinga | WASHINGTON, Oct. 04, 2023 (GLOBE NEWSWIRE) -- The National Cybersecurity Alliance (NCA), the nation's leading nonprofit empowering a more secure and interconnected world, today announced the kickoff of the 20th annual Cybersecurity Awareness Month, in partnership with the Cybersecurity and Infrastructure Security Agency (CISA), marking two decades of their collaborative effort to raise public awareness around cybersecurity education and responsibility. This year's theme, "Secure Our World," w... | https://www.benzinga.com/pressreleases/23/10/g35095065/national-cybersecurity-alliance-kicks-off-20th-annual-cybersecurity-awareness-month | Positive | 0.9997 |
DNUT | 2023-10-04T18:15:47.000Z | Krispy Kreme's Insomnia Divestiture May Not Boost Core Focus As Expected: Analyst Weighs In | benzinga | Truist Securities analyst Bill Chappell reiterated a Buy rating on the shares of Krispy Kreme Inc (NASDAQ: DNUT) with an unchanged price target of $20. Yesterday, the company announced that it is seeking strategic alternatives for its Insomnia Cookies to "unlock shareholder value and focus on its core strategy of producing, selling and distributing fresh doughnuts daily." Related: Krispy Kreme Considers Selling Insomnia Cookies Business For The Love Of Fresh Doughnuts Insomnia operates over 250... | https://www.benzinga.com/analyst-ratings/analyst-color/23/10/35093179/krispy-kremes-insomnia-divestiture-may-not-boost-core-focus-as-expected-analyst-wei | Positive | 0.9888 |
|
ANGO | 2023-10-04T18:09:13.000Z | Medical Devices Player AngioDynamics Exceeds Q1 Expectations, Sticks To Annual Guidance | benzinga | AngioDynamics Inc (NASDAQ: ANGO) has reported a Q1 FY24 adjusted EPS loss of $(0.12), beating the consensus of $(0.13) but higher than $(0.06) reported a year ago. Q1 sales decreased 3.5% Y/Y to $78.68 million, beating the analyst consensus of $77.69 million. On a pro forma basis, excluding sales of Dialysis and BioSentry, net sales increased 5.7% Y/Y. Med Tech net sales were $26.5 million, up 13.3% Y/Y, driven by ...Full story available on Benzinga.com... | https://www.benzinga.com/news/earnings/23/10/35089385/medical-devices-player-angiodynamics-exceeds-q1-expectations-sticks-to-annual-guidance | Negative | -0.8338 |
|
MAR | 2023-10-04T18:00:00.000Z | Nokia Oyj: Omien osakkeiden takaisinosto 04.10.2023 | https://ml-eu.globenewswire.com/Resource/Download/e6523d78-c43a-4057-8aa9-68206d3af4a8 | globenewswire | Nokia OyjPörssitiedote04.10.2023 klo 21.00... | https://www.globenewswire.com/news-release/2023/10/04/2754893/0/fi/Nokia-Oyj-Omien-osakkeiden-takaisinosto-04-10-2023.html | Neutral | 0 |
MAR | 2023-10-04T18:00:00.000Z | Nokia Corporation: Repurchase of own shares on 04.10.2023 | https://ml-eu.globenewswire.com/Resource/Download/e6523d78-c43a-4057-8aa9-68206d3af4a8 | globenewswire | Nokia CorporationStock Exchange Release4 October 2023 at 21:00 EEST... | https://www.globenewswire.com/news-release/2023/10/04/2754893/0/en/Nokia-Corporation-Repurchase-of-own-shares-on-04-10-2023.html | Positive | 0.9847 |
EU | 2023-10-04T18:00:00.000Z | Nokia Oyj: Omien osakkeiden takaisinosto 04.10.2023 | https://ml-eu.globenewswire.com/Resource/Download/e6523d78-c43a-4057-8aa9-68206d3af4a8 | globenewswire | Nokia OyjPörssitiedote04.10.2023 klo 21.00... | https://www.globenewswire.com/news-release/2023/10/04/2754893/0/fi/Nokia-Oyj-Omien-osakkeiden-takaisinosto-04-10-2023.html | Neutral | 0 |
EU | 2023-10-04T18:00:00.000Z | Nokia Corporation: Repurchase of own shares on 04.10.2023 | https://ml-eu.globenewswire.com/Resource/Download/e6523d78-c43a-4057-8aa9-68206d3af4a8 | globenewswire | Nokia CorporationStock Exchange Release4 October 2023 at 21:00 EEST... | https://www.globenewswire.com/news-release/2023/10/04/2754893/0/en/Nokia-Corporation-Repurchase-of-own-shares-on-04-10-2023.html | Positive | 0.9847 |
PACW | 2023-10-04T17:30:13.000Z | Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against PacWest Bancorp (PACW) | /next-assets/images/schema-image-default.png | benzinga | LOS ANGELES, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP ("GPM") reminds investors of the upcoming November 10, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired PacWest Bancorp ("PacWest" or the "Company") (NASDAQ:PACW, PACWP)) securities between February 28, 2022 and May 3, 2023, inclusive (the "Class Period"). If you suffered a loss on your PacWest investments or would like to inquire about p... | https://www.benzinga.com/pressreleases/23/10/g35094431/glancy-prongay-murray-llp-reminds-investors-of-looming-deadline-in-the-class-action-lawsuit-agains | Positive | 0.9539 |
ARKK | 2023-10-04T17:20:33.000Z | Cathie Wood's Flagship Fund's Chart Looks Awful | https://media.zenfs.com/en/ibd.com/4523176a766b377175eea9016e5b3844 | finance | Cathie Wood's ARK Innovation ETF's (ARKK) chart is flashing plenty of bearish signals. X The ARKK Innovation fund is Ark Invest's largest fund. The ETF had just over $8 billion in assets under management as of Aug. | https://www.investors.com/research/cathie-wood-flagship-etf-chart-looks-awful/?src=A00220&yptr=yahoo | Positive | 0.9612 |
BGS | 2023-10-04T17:17:50.000Z | B&G Foods Shares Diving Today: What's Going On? | benzinga | B&G Foods Inc (NYSE: BGS) shares are trading lower by around 11% after Piper Sandler analyst Michael S. Lavery downgraded it to Underweight from Neutral at a lowered price target to $8 from $14. The analyst is bearish as the company's Q3 US measured retail sales are declining (-11.5%, per SPINS/IR) and below analysts' expectations. Lavery now expects a Q3 organic revenue decline of 7.5% (vs. -4.5% projected earlier). The analyst also notes the ...Full story available on Benzinga.com... | https://www.benzinga.com/analyst-ratings/analyst-color/23/10/35092656/b-g-foods-shares-diving-today-whats-going-on | Negative | -0.7003 |
|
FOUR | 2023-10-04T17:16:41.000Z | Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Shift4 Payments, Inc. (FOUR) | /next-assets/images/schema-image-default.png | benzinga | LOS ANGELES, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP ("GPM") reminds investors of the upcoming October 19, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Shift4 Payments, Inc. ("Shift4" or the "Company") (NYSE:FOUR) securities between November 10, 2021 and April 18, 2023, inclusive (the "Class Period"). If you suffered a loss on your Shift4 investments or would like to inquire about pote... | https://www.benzinga.com/pressreleases/23/10/g35094204/glancy-prongay-murray-llp-reminds-investors-of-looming-deadline-in-the-class-action-lawsuit-agains | Negative | -0.5563 |
EU | 2023-10-04T17:14:10.000Z | Transaction in Own Shares | /next-assets/images/schema-image-default.png | benzinga | Transaction in Own Shares 04 October 2023 • • • • • • • • • • • • • • • • Shell plc (the ‘Company') announces that on 04 October 2023 it purchased the following number of Shares for cancellation. Aggregated information on Shares purchased according to trading venue: Date of purchase Number of Shares purchased Highest price paid Lowest price paid Volume weighted average price paid per share Venue Currency 04/10/2023 1,125,791 £25.8700 £25.0700 £25.3438 LSE GBP 04/10/2023 7,284 £25.81... | https://www.benzinga.com/pressreleases/23/10/g35094132/transaction-in-own-shares | Positive | 0.9451 |
CXE | 2023-10-04T17:14:10.000Z | Transaction in Own Shares | /next-assets/images/schema-image-default.png | benzinga | Transaction in Own Shares 04 October 2023 • • • • • • • • • • • • • • • • Shell plc (the ‘Company') announces that on 04 October 2023 it purchased the following number of Shares for cancellation. Aggregated information on Shares purchased according to trading venue: Date of purchase Number of Shares purchased Highest price paid Lowest price paid Volume weighted average price paid per share Venue Currency 04/10/2023 1,125,791 £25.8700 £25.0700 £25.3438 LSE GBP 04/10/2023 7,284 £25.81... | https://www.benzinga.com/pressreleases/23/10/g35094132/transaction-in-own-shares | Positive | 0.9451 |
EU | 2023-10-04T17:14:00.000Z | Transaction in Own Shares | globenewswire | Transaction in Own Shares... | https://www.globenewswire.com/news-release/2023/10/04/2754873/0/en/Transaction-in-Own-Shares.html | Positive | 0.9545 |